Literature DB >> 12379914

Excipient-drug interactions in parenteral formulations.

Michael J Akers1.   

Abstract

Excipients are added to parenteral formulations to enhance or maintain active ingredient solubility (solubilizers) and/or stability (buffers, antioxidants, chelating agents, cryo- and lyoprotectants). Excipients also are important in parenteral formulations to assure safety (antimicrobial preservatives), minimize pain and irritation upon injection (tonicity agents), and control or prolong drug delivery (polymers). These are all examples of positive or synergistic interactions between excipients and drugs. However, excipients may also produce negative effects such as loss of drug solubility, activity, and/or stability. This review article will highlight documented interactions, both synergistic and antagonistic, between excipients and drugs in parenteral formulations. The reader will gain better understanding and appreciation of the implications of adding formulation ingredients to parenteral drug products. Copyright 2002 Wiley-Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 91:2283-2300, 2002

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12379914     DOI: 10.1002/jps.10154

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  22 in total

1.  The effect of crystallizing and non-crystallizing cosolutes on succinate buffer crystallization and the consequent pH shift in frozen solutions.

Authors:  Prakash Sundaramurthi; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

Review 2.  Solubilizing excipients in oral and injectable formulations.

Authors:  Robert G Strickley
Journal:  Pharm Res       Date:  2004-02       Impact factor: 4.200

Review 3.  Importance and globalization status of good manufacturing practice (GMP) requirements for pharmaceutical excipients.

Authors:  Abubaker Abdellah; Mohamed Ibrahim Noordin; Wan Azman Wan Ismail
Journal:  Saudi Pharm J       Date:  2013-06-26       Impact factor: 4.330

4.  Dual Effect of Histidine on Polysorbate 20 Stability: Mechanistic Studies.

Authors:  Lin Zhang; Sandeep Yadav; Y John Wang; Olivier Mozziconacci; Christian Schӧneich
Journal:  Pharm Res       Date:  2018-01-16       Impact factor: 4.200

5.  Modification of the kinetic stability of immunoglobulin G by solvent additives.

Authors:  Jonas V Schaefer; Erik Sedlák; Florian Kast; Michal Nemergut; Andreas Plückthun
Journal:  MAbs       Date:  2018-04-25       Impact factor: 5.857

6.  Crystallization of trehalose in frozen solutions and its phase behavior during drying.

Authors:  Prakash Sundaramurthi; Thomas W Patapoff; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2010-09-02       Impact factor: 4.200

7.  Factors influencing time course of pain after depot oil intramuscular injection of testosterone undecanoate.

Authors:  Gideon Sartorius; Carolyn Fennell; Sasa Spasevska; Leo Turner; Ann J Conway; David J Handelsman
Journal:  Asian J Androl       Date:  2010-02-01       Impact factor: 3.285

8.  Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.

Authors:  Xiang Ling; Jiasheng Tu; Junqing Wang; Aram Shajii; Na Kong; Chan Feng; Ye Zhang; Mikyung Yu; Tian Xie; Zameer Bharwani; Bader M Aljaeid; Bingyang Shi; Wei Tao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-12-04       Impact factor: 15.881

9.  Determination of therapeutic equivalence of generic products of gentamicin in the neutropenic mouse thigh infection model.

Authors:  Andres F Zuluaga; Maria Agudelo; John J Cardeño; Carlos A Rodriguez; Omar Vesga
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 10.  Beyond conventional antibiotics - New directions for combination products to combat biofilm.

Authors:  Danir Fanisovich Bayramov; Jennifer Ann Neff
Journal:  Adv Drug Deliv Rev       Date:  2016-08-03       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.